File: '\\swfile\EmailIn\20251218 090032 Attachment 2025-12-18 MUSL - Unit PP.docx'

Promino Cancels Previously Announced Non-Brokered Private Placement and Announces Proposed New Private Plcement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

BURLINGTON, ON - December 18, 2025 - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) ("Promino" or the "Company") announces that it will not be proceeding with the non-brokered private placement of secured convertible debentures previously announced on December 9 and December 12, 2025.

The Company now intends to complete a non-brokered private placement for aggregate gross proceeds of up to $1,000,000 through the issuance of up to 50,000,000 units of the Company ("Units") at a price of $0.02 per Unit (the "New Offering"). The Company may increase the size of the New Offering by up to 25,000,000 additional Units for aggregate proceeds of up to $1,500,000. Each Unit will consist of one common share (each, a "Share") and one common share purchase warrant (each, a "Warrant"), with each Warrant being exercisable to purchase one additional Share at a price of $0.06 for twelve (12) months from the date of issuance.

The Company intends to use the net proceeds from the New Offering to (a) accelerate growth through investments inventory and (b) for general corporate purposes.

The New Offering is expected to close on or about January 30, 2026 and is subject to execution of subscription agreements by the placees and to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange.

All securities issued in connection with the New Offering will be subject to a four month and one day statutory resale restriction pursuant to applicable Canadian securities laws.

The securities being offered under the New Offering have not been and will not be registered under the United States Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy nor will there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.

About Promino Nutritional Sciences Inc.

Promino Nutritional Sciences is a Canadian innovation company focused on science-based, clinically proven nutrition for muscle health and recovery. Its core product, Rejuvenate Muscle Health(TM), is a clinically researched amino acid formula designed to rebuild, restore, and rejuvenate muscle tissue.

The Company also produces Promino(TM) - NSF Certified for Sport(TM), trusted by elite athletes. Promino's ambassadors include Stanley Cup Champion Jack Eichel (Vegas Golden Knights) and MLB legend Jose Bautista.

Learn more at www.drinkpromino.com and www.rejuvenatemuscle.com.

Forward-Looking Statements and Financial Outlook

This news release contains forward-looking statements and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipates", "expects" and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to the expectations of management regarding the proposed New Offering, the expectations of management regarding the use of proceeds of the New Offering, closing conditions for the New Offering, the expiry of hold periods for securities distributed pursuant to the New Offering, and Canadian Securities Exchange approval of the proposed New Offering. All statements other than statements of historical fact, included in this news release are forward-looking statements that involve risks and uncertainties. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements including that: the Company may not complete the New Offering on terms favorable to the Company or at all; the Canadian Securities Exchange may not approve the New Offering; the proceeds of the New Offering may not be used as stated in this news release; the Company may be unable to satisfy all of the conditions to closing of the New Offering; and those additional risks set out in the Company's public documents filed on SEDAR+ at www.sedarplus.ca There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.

For further information about Promino:

Moira Ong, CFO, mong@drinkpromino.com, 1-855-348-1970 (extension 204)